Bio Green Med Solution, Inc. carries a market capitalization of 2.32M, placing it among publicly traded companies globally. Its enterprise value stands at 51,461.50, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.32M |
| Enterprise Value | 51,461.50 |
Bio Green Med Solution, Inc. currently has 5.52M shares outstanding.
| Shares Outstanding | 5.52M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 2.22, and the price-to-book ratio stands at -0.01.
| PE Ratio | N/A |
| PS Ratio | 2.22 |
| PB Ratio | -0.01 |
| P/TBV Ratio | 0.65 |
| P/FCF Ratio | -1.88 |
| P/OCF Ratio | -1.88 |
| EV / Sales | 0.03 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Bio Green Med Solution, Inc. maintains a current ratio of 7.06, meaning it holds 7.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 7.06 |
| Quick Ratio | 5.69 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -55.12 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.63 |
| Income Tax | 37,000.00 |
| Effective Tax Rate | N/A |
Bio Green Med Solution, Inc.'s stock has declined approximately -82.39203% over the past 52 weeks. The 50-day moving average sits at 1.01, while the 200-day moving average is 2.31.
| Beta (5Y) | N/A |
| 52-Week Price Change | -82.39203% |
| 50-Day Moving Average | 1.01 |
| 200-Day Moving Average | 2.31 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Bio Green Med Solution, Inc. generated 1.53M in revenue and converted that into -3.11M in net income, yielding earnings per share of -0.92. EBITDA reached -3.63M, while operating income came in at -3.64M.
| Revenue | 1.53M |
| Gross Profit | 281,000.00 |
| Operating Income | -3.64M |
| Pretax Income | -3.08M |
| Net Income | -3.11M |
| EBITDA | -3.63M |
| EBIT | -3.64M |
| Earnings Per Share (EPS) | -0.92 |
Total book value stands at -454.60M, with working capital of 4.83M providing operational flexibility.
| Cash & Cash Equivalents | 3.34M |
| Total Debt | N/A |
| Net Debt | -3.34M |
| Equity (Book Value) | -454.60M |
| Book Value Per Share | -134.08 |
| Working Capital | 4.83M |
Bio Green Med Solution, Inc. produced -1.80M in operating cash flow over the past twelve months. After subtracting -1,000.00 in capital expenditures, free cash flow totaled -1.80M - equivalent to -0.53 per share.
| Operating Cash Flow | -1.80M |
| Capital Expenditures | -1,000.00 |
| Free Cash Flow | -1.80M |
| FCF Per Share | -0.53 |
Bio Green Med Solution, Inc. operates with a gross margin of 18.43, reflecting its pricing power and cost economics. The operating margin of -238.49 and net profit margin of -204.20 provide insight into operational efficiency.
| Gross Margin | 18.43 |
| Operating Margin | -238.49 |
| Pretax Margin | -201.77 |
| Profit Margin | -204.20 |
| EBITDA Margin | -238.10 |
| Dividend Per Share | 0.02 |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -50.82 |
| FCF Yield | -53.09 |
Bio Green Med Solution, Inc. posts an Altman Z-Score of -104.43, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -104.43 |